Synergy Potential of Indole Alkaloids and Its Derivative against Drug-resistantEscherichia coli

A new antibiotic kills pathogens without detectable resistance

(2015) Losee L. Ling et al.   NATURE

Tricyclic Sesquiterpenes FromVetiveria zizanoides(L.) Nash as Antimycobacterial Agents

(2013) Gaurav R. Dwivedi et al.   Chemical Biology & Drug Design

Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid-ResistantEscherichia coli

(2013) Anupam Maurya et al.   Chemical Biology & Drug Design

4-Hydroxy-α-Tetralone and its Derivative as Drug Resistance Reversal Agents in Multi Drug ResistantEscherichia coli

(2013) Gaurav R. Dwivedi et al.   Chemical Biology & Drug Design

The Future of Antibiotics and Resistance

(2013) Brad Spellberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preparative Isolation of Bioenhancer Loganetin fromsf Alstonia scholarisby Fast Centrifugal Partition Chromatography

(2013) Anupam Maurya et al.   SEPARATION SCIENCE AND TECHNOLOGY

Bioactivity guided isolation of antipsychotic constituents from the leaves of Rauwolfia tetraphylla L.

(2012) Shikha Gupta et al.   FITOTERAPIA

Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies

(2012) Y. Hu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evidence for Serpentine as a novel antioxidant by a redox sensitive HABP1 overexpressing cell line by inhibiting its nuclear translocation of NF-κB

(2011) Shubhra Dutta et al.   FREE RADICAL RESEARCH

Bioenhancing and Antimycobacterial Agents fromAmmannia multiflora

(2011) Harish Upadhyay et al.   PLANTA MEDICA

Botanical Drugs, Synergy, and Network Pharmacology: Forth and Back to Intelligent Mixtures

(2011) Jürg Gertsch   PLANTA MEDICA

The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020

(2010)   CLINICAL INFECTIOUS DISEASES

Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections

(2010) Julian G. Hurdle et al.   NATURE REVIEWS MICROBIOLOGY

Hospital-Acquired Infections Due to Gram-Negative Bacteria

(2010) Anton Y. Peleg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multidrug Resistance in Bacteria

(2009) Hiroshi Nikaido   Annual Review of Biochemistry

The changing epidemiology of resistance

(2009) P. M. Hawkey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Has the era of untreatable infections arrived?

(2009) D. M. Livermore   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mechanisms of drug combinations: interaction and network perspectives

(2009) Jia Jia et al.   NATURE REVIEWS DRUG DISCOVERY

Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria

(2008) Jean-Marie Pagès et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Utilization of membrane vesicle preparations to study drug–ABC transporter interactions

(2008) Hristos Glavinas et al.   Expert Opinion on Drug Metabolism & Toxicology

Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities

(2008) Marta Martins et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS